RARE vs TISI · rev $350.0M vs rev $228.7M
Ultragenyx (RARE) versus Team Inc (TISI) — a side-by-side from cached financials, not a winner call.
Ultragenyx (RARE) is a biotechnology company listed on US.
Team Inc (TISI) is a specialty business services company listed on NYSE.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
Latest reported TISI revenue for 2026-06-30 was $228.7M. Net income was -$6.8M. Revenue was up 6.3% from 2026-03-31 to 2026-06-30. TISI currently screens at market cap $77.0M.
RARE currently screens at market cap $2.79B. TISI currently screens at market cap $77.0M.
Not investment advice. Open the RARE and TISI stock pages for the full models.
Not investment advice.